Finnmarkssykehuset HF
- Address
- lock Available on a paid plan
Nutritional and Metabolic Diseases at Finnmarkssykehuset HF
Research at the Department for Psychiatry and Addiction Medicine, Clinic Alta includes trials focused on obesity in adolescents. The studies are designed to evaluate whether a new treatment approach can help improve weight-related outcomes and support healthier long-term management.
- Obesity in adolescents and weight reduction
- Testing a new therapy to improve treatment effectiveness
This work reflects a growing interest in combining medical treatment with behavioral support to address pediatric obesity in a practical, patient-centered way.
Psychiatry and Psychology at Finnmarkssykehuset HF
The site is also involved in clinical research on mental disorders, especially comorbid dependencies to amphetamines and opioids. These trials aim to better understand and improve care for people living with substance use-related conditions.
- Amphetamine dependence in patients receiving opioid agonist treatment
- Evaluating a treatment strategy to reduce illicit stimulant use
By exploring approaches that may help reduce ongoing drug use, the research supports efforts to improve treatment outcomes in addiction medicine and strengthen recovery-focused care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Helse Bergen HF1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Finnmarkssykehuset HF
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dexamfetamine Sulfate in Reducing Illicit Amphetamine Use in Adults with Comorbid Amphetamine and Opioid Dependence Undergoing Opioid Agonist Therapy | Helse Bergen HF | Phase II | Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamfetamine Sulfate | 1 | Unknown | 2024-09-18 | 2024-09-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.